Nachrichten zur Agenus Inc. Aktie

Agenus names new chief commercial officer

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Andy Hurley Named Agenus Chief Commercial Officer

LEXINGTON, Mass., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive…

Agenus Announces Agenus Insights - Virtual R&D Miniseries

LEXINGTON, Mass., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive…

Agenus Announces New Responses for AGEN1181

LEXINGTON, Mass., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive…

Thinking about buying stock in Canopy Growth Corp, 3D Systems, Bilibili, Agenus, or Vyne Therapeutics?

NEW YORK , Feb. 4, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CGC,…

Agenus Announces Positive Preliminary Results of iNKT Cell Therapy Trial in COVID-19

LEXINGTON, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive…

The Only Play On Agenus

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Agenus partners with Nelum for zalifrelimab combination in pancreatic cancer

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Agenus Enters into Clinical Collaboration with Nelum for Zalifrelimab Combination

LEXINGTON, Mass., Jan. 26, 2021 (GLOBE NEWSWIRE) -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive…

AGENUS INC: 8-K Report

8-K...…

Agenus extends timeline for U.S. balstilimab application after two late responders identified

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

AGENUS INC: 8-K Report

8-K...…

Agenus to Participate in Evercore ISI 3rd Annual HealthCONx Conference

LEXINGTON, Mass., Nov. 25, 2020 (GLOBE NEWSWIRE) -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive…

Agenus to Participate in Fireside Chat at the Jefferies 2020 Virtual London Healthcare Conference

LEXINGTON, Mass., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive…

Agenus: A Buy With iNKT Therapy, MK-4830 Milestone

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

XOMA receives first royalty payment from Agenus

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Agenus secures $10M in milestone payment related to MK-4830

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

An Agenus-discovered first-in-class ILT4 antibody, MK-4830, enters Phase 2

LEXINGTON, Mass., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive…

Agenus Presents Additional Clinical Responses and Novel Biomarker Data at SITC2020

LEXINGTON, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive…

Why Agenus Stock Is Popping Today

An off-the-shelf cell therapy for COVID-19 is sending the biotechs shares higher today....…

Agenus Doses First COVID-19 Patient with iNKT Cell Therapy

LEXINGTON, Mass., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive…

Agenus Inc. (AGEN) CEO Garo Armen on Q3 2020 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Agenus (AGEN) Reports Q3 Loss, Tops Revenue Estimates

Agenus (AGEN) delivered earnings and revenue surprises of -7.69% and 5.95%, respectively, for the quarter ended September 2020. Do the…

AGENUS INC: 8-K Report

FORM 8-K...…

Agenus EPS misses by $0.02, beats on revenue

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Agenus R&D Update & Third Quarter Financial Report

LEXINGTON, Mass., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive…

Agenus to Report Third Quarter Earnings

Conference Call and Webcast on Thursday, October 29, 2020 from 8:30 – 9:30 am Conference Call and Webcast on Thursday,…

Agenus to Present on Seven Novel Programs at SITC 2020

LEXINGTON, Mass., Oct. 14, 2020 (GLOBE NEWSWIRE) -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive…

Agenus Vs. Seattle Genetics Cervical Cancer Clinical Trial Results

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Agenus First Data From MK-4830: Another Reason To Buy

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Agenus (AGEN) Initiates Rolling BLA Submission of Balstilimab

Agenus (AGEN) initiates the rolling submission of its BLA to the FDA for balstilimab alone for the treatment of recurrent/metastatic…

Agenus initiates rolling BLA submission of Balstilimab

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Agenus Initiates Rolling BLA Submission of Balstilimab for Recurrent/Metastatic Cervical Cancer

LEXINGTON, Mass., Sept. 18, 2020 (GLOBE NEWSWIRE) -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive…

Agenus PD-1 inhibitor shows positive effect in cervical cancer

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Agenus balstilimab shows clinical activity in both PD-L1 positive and negative tumors

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Agenus Presents Results from Two Large Cervical Cancer Trials at ESMO

LEXINGTON, Mass., Sept. 18, 2020 (GLOBE NEWSWIRE) -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive…

Dr. Jennifer Buell Speaks Live at Scientific American Inaugural Fireside Chat Series 18 Minutes With

LEXINGTON, Mass., Sept. 17, 2020 (GLOBE NEWSWIRE) -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive…

Agenus to Participate in Webcast Hosted by William Blair on ESMO2020 Results and Novel Pipeline

LEXINGTON, Mass., Sept. 17, 2020 (GLOBE NEWSWIRE) -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive…

Thinking about buying stock in Avinger, Vascular Biogenics, Intra-Cellular Therapies, Agenus, or Co-Diagnostics?

NEW YORK , Sept. 11, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AVGR,…

Return On Capital Employed Overview: Agenus

During Q2, Agenus (NASDAQ: AGEN) brought in sales totaling $26.95 million. However, earnings decreased 17.0%, resulting in a loss of…

Why Agenus Is Soaring 23.6% Today

Investor optimism is increasing ahead of an oral presentation at ESMO 2020....…

Agenus, Achieve Life Sciences leads gainers, Satsuma Pharmaceuticals, Precipio among losers

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Paul Clark Joins Agenus Board of Directors

LEXINGTON, Mass. , Aug. 31, 2020 /PRNewswire/ -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology…

Agenus Announces ESMO Oral Presentation of Two Clinical Trials of Balstilimab Alone and in Combination with Zalifrelimab in Recurrent or Metastatic Cervical Cancer

LEXINGTON, Mass. , Aug. 26, 2020 /PRNewswire/ -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology…